Lingshu Wang, Ph.D.

Staff Scientist 

Contact: For contact information, search the NIH Enterprise Directory.


Ph.D., Shanghai JiaoTong University, China

Languages Spoken: Mandarin


Dr. Wang leads a team to assess neutralization activities of vaccinated animal sera and monoclonal antibodies against coronaviruses (CoV) and influenza. She designs and evaluates subunit and gene-based vaccines against CoV, flu, Enterovirus-D68 (EV-D68). Additionally, she isolates and identifies potent neutralizing antibodies against SARS-CoV-2 variants of concern and other CoVs.